Profile of reslizumab in eosinophilic disease and its potential in the treatment of poorly controlled eosinophilic asthma
Garry M WalshDivision of Applied Medicine, School of Medicine and Dentistry, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UKAbstract: Eosinophils are important proinflammatory cells that make a major contribution to the inflammation seen in allergic diseases including asthma. Int...
Guardado en:
Autor principal: | Walsh GM |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9f1517d6c94a4b8e9e05febf8080da4a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Patient profiles and clinical utility of mepolizumab in severe eosinophilic asthma
por: Haldar P
Publicado: (2017) -
New horizons for the treatment of severe, eosinophilic asthma: benralizumab, a novel precision biologic
por: Caminati M, et al.
Publicado: (2019) -
Eosinophilic esophagitis: A potential complication of sublingual immunotherapy
por: Knežević Snežana B., et al.
Publicado: (2021) -
Eosinophilic endotype of chronic obstructive pulmonary disease: similarities and differences from asthma
por: Andrew Li, et al.
Publicado: (2021) -
Diagnosing eosinophilic esophagitis
por: Díaz-Oliva,Sarah Esther, et al.
Publicado: (2021)